Hormone therapy or androgen deprivation therapy (ADT) comprises a group of medical treatments designed to deprive prostate cancer cells of the male hormone testosterone.
by Dr. Tom Pickles
Active surveillance has become a trusted choice for many men with low-risk cancer
Active surveillance (AS) has become a mainstream option for men with early prostate cancer, as more supporting evidence has increased patients’ and physicians’ confidence in the approac
by Dr. Ana Ots and Dr. Juanita Crook
Radiation therapy then, now and in the future
Great strides have been made in radiation therapy over the last few decades, from refinements in the precision of external beam radiation delivery to the development of internal seed implants (brac
by Dr. B. Joyce Davison
A Saskatoon program helps men communicate their treatment preferences and values
Prostate cancer is unique in that no other disease condition with a comparably high incidence rate has so many available treatment alternatives — yet so few certainties about which one is bes
by Dr. Andrew Loblaw and Dr. Tom Pickles
Long-term results make brachytherapy an interesting option for low- and intermediate-risk disease
Radiation is a standard treatment option for men with prostate cancer. It targets both normal tissues and cancer cells, but cancer cells are more sensitive to being killed by the radiation.
by Dr. Charles Catton
The high-tech world of prostate radiotherapy
Prostate cancer arises in a small, relatively inaccessible organ located deep in the pelvis, surrounded by sensitive structures like the bladder, rectum and nerves that control erectile function.